Table 1.
Patients (n=80) | |
---|---|
Age (years) | 55 (25 - 89) |
| |
FIGO stage | |
| |
I | 10 (12%) |
II | 32 (40%) |
III | 27 (34%) |
IV | 11 (14%) |
| |
Histology | |
| |
Squamous cell ca. | 69 (86%) |
Adenocarcinoma | 11 (14%) |
| |
Brachytherapy | |
| |
Low-dose-rate | 76 (95%) |
None (EBRT only) | 4 (5%) |
| |
Chemotherapy | 25 (31%) |